Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Fludarabine, cyclophosphamide, and melphalan (FCM) preconditioning in haploidentical hematopoietic stem cell transplantation for severe aplastic anemia: Update of a prospective, multicenter, single-arm clinical study

Xiaoping Li, Yali Zhou, Bo Nie, Peng Zhao, Jiong Hu, Chun Wang, Hao Zhang, Xiaolin Yin, Wang Sanbin

Blood (2025) 146 (Supplement 1): 4201.

https://doi.org/10.1182/blood-2025-4201

Published: 2025

Journal Articles

TBI-ATG based conditioning regimen is a promising approach for adult patients with refractory and relapsed peripheral T cell lymphoma undergoing allogeneic peripheral blood stem cell transplantation

Chuxian Zhao, Daolin Wei, Huixia Liu, Ying Jiang, Shan Shao, Chun Wang, JUN Zhu

Blood (2025) 146 (Supplement 1): 4190.

https://doi.org/10.1182/blood-2025-4190

Published: 2025

Journal Articles

A tandem bispecific nanobody CAR (SL1703) T cells targeting CD19/BCMA for refractory or relapsed multiple myeloma as salvage treatment after BCMA CAR-T therapy failure

Su Li, Xin Li, Chengwei Jin, Wei Liu, Yan Zhao, Jingjing Wang, Chun Wang, Jian Hou, Jing PAN

Blood (2025) 146 (Supplement 1): 5934.

https://doi.org/10.1182/blood-2025-5934

Published: 2025

Journal Articles

SL0439: A structure-tuned bispecific nanobody CAR-T cells targeting BCMA/GPRC5D for relapsed/refractory multiple myeloma with extramedullary disease

Su Li, JUN Zhu, Chengwei Jin, Wei Liu, Yan Zhao, Jingjing Wang, Chun Wang, Jian Hou, Jing PAN

Blood (2025) 146 (Supplement 1): 4146.

https://doi.org/10.1182/blood-2025-4146

Published: 2025

Journal Articles

Daratumumab and venetoclax-based combined regimen for relapsed/refractory T-lymphoblastic leukemia/lymphoma

Shan Shao, Chuxian Zhao, Huixia Liu, Chun Wang, JUN Zhu, Daolin Wei, Ying Jiang

Blood (2025) 146 (Supplement 1): 1568.

https://doi.org/10.1182/blood-2025-1568

Published: 2025

Journal Articles

Short-Term Substitution of Calcineurin Inhibitors (CNIs) with Recombinant Humanized Anti-CD25 Monoclonal Antibody (anti-CD25 rhMAb) As aGVHD Prophylaxis in Cnis Intolerant Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Shan Shao, Huixia Liu, Ying Jiang, Su Li, Daolin Wei, JUN Zhu, Chun Wang, Chuxian Zhao

Blood (2023) 142 (Supplement 1): 7007.

https://doi.org/10.1182/blood-2023-173673

Published: 2023

Journal Articles

TBI/Ratg-Based Conditioning for Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in 11 Cases of Chemotherapy-Resistant Advanced-Stage Peripheral T-Cell Lymphoma

JUN Zhu, Rong Xu, Chun Wang, Chuxian Zhao, Ying Jiang, Daolin Wei, Shan Shao, Huixia Liu, Su Li

Blood (2023) 142 (Supplement 1): 6981.

https://doi.org/10.1182/blood-2023-174062

Published: 2023

Journal Articles

Impact of Immunosuppression Intensified Conditioning Regimen for Patients with Strong Positive Pre-Transplantation Donor Specific Anti-HLA Antibodies (DSAs) Undergoing Haploidentical Hematopoietic Stem Cell Transplantation

Huixia Liu, Daolin Wei, Shan Shao, Ying Jiang, Su Li, JUN Zhu, Chun Wang, Chuxian Zhao

Blood (2023) 142 (Supplement 1): 6989.

https://doi.org/10.1182/blood-2023-174240

Published: 2023

Journal Articles

Real-World Effectiveness and Safety of Hetrombopag for Delayed Platelet Engraftment Post-Allogeneic Hematopoietic Stem Cell Transplantation

JUN Zhu, Yun Lou, Chuxian Zhao, Ying Jiang, Daolin Wei, Chun Wang, Shan Shao, Huixia Liu, Su Li

Blood (2023) 142 (Supplement 1): 6950.

https://doi.org/10.1182/blood-2023-178605

Published: 2023

Journal Articles

Identification of a Novel FAM135B Cancer Susceptibility Mutation in a Family with Multiple Cases of MLL -Rearranged AML

Li-li PAN, Yanling Sun, Xiaolin Lai, Luya Ye, Xue-chun Wang, Zhi-xiang Chen, Yuanhua Cai, Yi Zheng, Yang Li, Ya-ping Wang, Xin Liu, Shao-yuan Wang, Qian-fei Wang

Blood (2022) 140 (Supplement 1): 9107.

https://doi.org/10.1182/blood-2022-165170

Published: 2022

Journal Articles

Diagnosis of Lung Complication in Allogeneic Stem Cell Transplantation By Combined Use of Multiple Methods through Bronchoscopic Alveolar Lavage

Su Li, master's degree, Xianmin Song, MD, Liping Wan, Chun Wang, Yin Tong, Master's degree, Chongmei Huang, MD, Xiaoqian Xu, Master's degree, Yu CAI, MD, Guogang Xie, MD, Rong Tang, MD, Yi Sun, PhD, Aihua Bao, MD, Jun Yang, MD

Blood (2019) 134 (Supplement_1): 4626.

https://doi.org/10.1182/blood-2019-127950

Published: 2019

Journal Articles

Favorable Overall Survival in Refractory Diffuse Large B-Cell Lymphoma When Responded to High-Dose Etoposide Mobilization Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation

Yu CAI, MD, Chun Wang, Xianmin Song, Liping Wan, Su Li, Jun Yang, Jieling Jiang, MD

Blood (2018) 132 (Supplement 1): 5758.

https://doi.org/10.1182/blood-2018-99-111868

Published: 2018

Journal Articles

Low Dose Anti-Thymocyte Globulin Plus Low Dose Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in Haploidentical Peripheral Blood Stem Cell Transplantation for Patients with Hematologic Malignancies: A Prospective, Phase II Study

Jun Yang, Jiang Jieling, Yu CAI, MD, Su Li, Liping Wan, Jun Zhu, Huixia Liu, Shan Shao, Haitao Bai, Chun Wang, Jiong Hu, MD, Xianmin Song

Blood (2018) 132 (Supplement 1): 4575.

https://doi.org/10.1182/blood-2018-99-110727

Published: 2018

Journal Articles

Molecular Mechanisms of EML in AML1/ETO+ AML and Its Targeting Treatments

Fan Yi Meng, MD, Ling Jiang, MD PhD, Qingxiu Zhong, MD, Li Chun Wang, MD, Guopan Yu, MD, Xinhua Zhu, MD

Blood (2014) 124 (21): 5953.

https://doi.org/10.1182/blood.V124.21.5953.5953

Published: 2014

Journal Articles

MiR-146a Expression Level As a Molecular Marker in Acute Promyleocytic Leukemia

Hua Zhong, Chun Wang, Chen Fangyuan, Lan Xu, Jihua Zhong, HU Jiong

Blood (2012) 120 (21): 4821.

https://doi.org/10.1182/blood.V120.21.4821.4821

Published: 2012

Journal Articles

Re-Assessment of the Prognostic Value of International Prognostic Index (IPI) and Revised IPI (R-IPI) in Patients with Diffuse Large B-Cell Lymphoma Treated with or without Rituximab in Chinese Populations: A Retrospective Multicenter Study by Shanghai Lymphoma Research Group

Honghui Huang, Fei Xiao, Fangyuan Chen, Ting Wang, Junmin Li, Jianmin Wang, Junning Cao, Chun Wang, Shanhua Zou

Blood (2011) 118 (21): 2649.

https://doi.org/10.1182/blood.V118.21.2649.2649

Published: 2011

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) with FBA/FBAA Regimen Based Reduced-Intensity Conditioning: A Multicenter Clinical Trial in China

Jianmin Wang, Weiping Zhang, Jiong Hu, Chun Wang, Xinghua Chen, Jian Hou, MD, Yongping Song

Blood (2011) 118 (21): 1953.

https://doi.org/10.1182/blood.V118.21.1953.1953

Published: 2011

Journal Articles

Leukemia Cell-Derived Exosomes Targeted Dendritic Cells Can Induce More Strong Anti-Leukemia Response Than Exosomes Alone

Chang Sheng, Jing Sun, Chun Wang, Siguo Hao, Sr.

Blood (2011) 118 (21): 4278.

https://doi.org/10.1182/blood.V118.21.4278.4278

Published: 2011

Journal Articles

PAD Induction Therapy Followed by Autologous Peripheral Blood Stem Cell Transplant (APBSCT) as Upfront Treatment for Myeloma (MM) in Chinese Patients.

Albert Kwok Wai Lie, DePei Wu, Chun Wang, Chor Sang Chim, Raymond Liang, Zhengzheng Fu, Liping Wan

Blood (2009) 114 (22): 4367.

https://doi.org/10.1182/blood.V114.22.4367.4367

Published: 2009

Journal Articles

Reduced-Intensity Conditioning with FBA/FBAA Regimen Is Feasible for Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML): Interim Results of a Multicenter Clinical Trial in China.

Jianmin Wang, M.D., Jiong Hu, M.D., Chun Wang, M.D., Xinghua Chen, M.D., Jian Hou, M.D., Weiping Zhang, M.D., Wei Tang, M.D., Shike Yan, M.D., Xi Zhang, M.D., Lili Zhou, M.D., Jun Hou, M.D.

Blood (2009) 114 (22): 196.

https://doi.org/10.1182/blood.V114.22.196.196

Published: 2009

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Fludarabine, cyclophosphamide, and melphalan (FCM) preconditioning in haploidentical hematopoietic stem cell transplantation for severe aplastic anemia: Update of a prospective, multicenter, single-arm clinical study

TBI-ATG based conditioning regimen is a promising approach for adult patients with refractory and relapsed peripheral T cell lymphoma undergoing allogeneic peripheral blood stem cell transplantation

A tandem bispecific nanobody CAR (SL1703) T cells targeting CD19/BCMA for refractory or relapsed multiple myeloma as salvage treatment after BCMA CAR-T therapy failure

SL0439: A structure-tuned bispecific nanobody CAR-T cells targeting BCMA/GPRC5D for relapsed/refractory multiple myeloma with extramedullary disease

Daratumumab and venetoclax-based combined regimen for relapsed/refractory T-lymphoblastic leukemia/lymphoma

Short-Term Substitution of Calcineurin Inhibitors (CNIs) with Recombinant Humanized Anti-CD25 Monoclonal Antibody (anti-CD25 rhMAb) As aGVHD Prophylaxis in Cnis Intolerant Patients after Allogeneic Hematopoietic Stem Cell Transplantation

TBI/Ratg-Based Conditioning for Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in 11 Cases of Chemotherapy-Resistant Advanced-Stage Peripheral T-Cell Lymphoma

Impact of Immunosuppression Intensified Conditioning Regimen for Patients with Strong Positive Pre-Transplantation Donor Specific Anti-HLA Antibodies (DSAs) Undergoing Haploidentical Hematopoietic Stem Cell Transplantation

Real-World Effectiveness and Safety of Hetrombopag for Delayed Platelet Engraftment Post-Allogeneic Hematopoietic Stem Cell Transplantation

Identification of a Novel FAM135B Cancer Susceptibility Mutation in a Family with Multiple Cases of MLL -Rearranged AML

Diagnosis of Lung Complication in Allogeneic Stem Cell Transplantation By Combined Use of Multiple Methods through Bronchoscopic Alveolar Lavage

Favorable Overall Survival in Refractory Diffuse Large B-Cell Lymphoma When Responded to High-Dose Etoposide Mobilization Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation

Low Dose Anti-Thymocyte Globulin Plus Low Dose Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in Haploidentical Peripheral Blood Stem Cell Transplantation for Patients with Hematologic Malignancies: A Prospective, Phase II Study

Molecular Mechanisms of EML in AML1/ETO+ AML and Its Targeting Treatments

MiR-146a Expression Level As a Molecular Marker in Acute Promyleocytic Leukemia

Re-Assessment of the Prognostic Value of International Prognostic Index (IPI) and Revised IPI (R-IPI) in Patients with Diffuse Large B-Cell Lymphoma Treated with or without Rituximab in Chinese Populations: A Retrospective Multicenter Study by Shanghai Lymphoma Research Group

Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) with FBA/FBAA Regimen Based Reduced-Intensity Conditioning: A Multicenter Clinical Trial in China

Leukemia Cell-Derived Exosomes Targeted Dendritic Cells Can Induce More Strong Anti-Leukemia Response Than Exosomes Alone

PAD Induction Therapy Followed by Autologous Peripheral Blood Stem Cell Transplant (APBSCT) as Upfront Treatment for Myeloma (MM) in Chinese Patients.

Reduced-Intensity Conditioning with FBA/FBAA Regimen Is Feasible for Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML): Interim Results of a Multicenter Clinical Trial in China.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only